COMMENTARY: Enoxaparin was more effective than unfractionated heparin in STEMI, regardless of type of fibrinolytic agent used
- Benefits of long-term post-MI anticoagulation outweigh the costs. // Modern Medicine;Jul95, Vol. 63 Issue 7, p49
Presents an abstract of the articles `Costs and effects of long-term oral anticoagulant treatment after myocardial infarction,' by P.F.M. van Bergen, J.J.C. Jonker et al, published in the March 22-29, 1995 issue of the `Journal of the American Medical Association,' and `Economics and efficacy in...
- Oral anticoagulants--the totem and the taboo. Breckenridge, A. // British Medical Journal;2/21/1976, Vol. 1 Issue 6007, p419
Investigates the efficacy of oral anticoagulants. Controversy on the use of anticoagulants in acute myocardial infarction; Conduction of a clinical trial on the effectiveness of anticoagulants; Conclusion that anticoagulants is of no benefits as a treatment to diseases.
- Enoxaparin was more effective than unfractionated heparin in STEMI, regardless of type of fibrinolytic agent used. // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p63
The article offers information on a study that investigates the effectiveness of enoxaparin, in comparison with unfractionated heparin (UFH), for patients with ST-elevation myocardial infarction (STEMI), irrespective of the type of fibrinolytic agent used. It describes the method and patients'...
- Can BRIGHT Restore the Glow of Bivalirudin? Cavender, Matthew A.; Faxon, David P. // JAMA: Journal of the American Medical Association;4/7/2015, Vol. 313 Issue 13, p1323
The authors focus on the results of the Bivalirudin in Acute Myocardial Infarction Versus Heparin and Glycoprotein IIb/IIIa Inhibitors (GPI) Plus Heparin Trial (BRIGHT) conducted by Y. Han and colleagues. The trial studies direct thrombin inhibitor bivalirudin in patients undergoing percutaneous...
- Heparin for acute MI is not necessarily the best course. // Modern Medicine;Jul98, Vol. 66 Issue 7, p29
Presents an abstract of the article `Use and Effectiveness of Intravenous Heparin Therapy for Treatment of Acute Myocardial Infarction in the Elderly,' by H. M. Krumholz, J. Hennen, et al from the `Journal of American College Cardiol' dated April 1998.
- COMMENTARY: Fondaparinux reduced death or reinfarction in acute ST-segment elevation myocardial infarction. Borzak, Steven // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p29
The article comments on the study related to the use of the drug fondaparinux to treat patients with acute ST-segment elevation myocardial infarction (STEMI). In the study fondaparinux was found useful in reducing death. These trials support the use of anticoagulant therapy in patients with...
- Clot-busters for `brain attacks'. E.B. // Medical Update;Mar97, Vol. 20 Issue 9, p4
Examines the use of clot-dissolving drugs in treating heart attack patients. Problems faced by physicians in treating stroke; Seeming neglect of physicians on using an aggressive approach to treating stroke.
- Antithrombotic drug called useful adjunct to streptokinase. // Geriatrics;May94, Vol. 49 Issue 5, p20
Reports on a medical trial using an antithrombotic agent called Hirudin in the treatment of patients with acute myocardial infarction (MI). Usefulness as an adjunct to streptokinase; Inhibition of both free and clot-bound thrombin; Trend toward lower rates of mortality and clinical events.
- Anticoagulant Therapy in the Relatively Young Male with Myocardial Infarction. Myers Jr., John E.; Bauer, Frank L. // Annals of Internal Medicine;Nov61, Vol. 55 Issue 5, p760
Investigates anticoagulant therapy for acute myocardial infarction in young male patients. Comparison of anticoagulant and non-anticoagulant therapy; Rationale for anticoagulant therapy; Mortality rates after therapy.